Clinical Trials in Yamanashi, Japan
8 recruiting
Showing 1–8 of 8 trials
Recruiting
Phase 3
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Multiple Myeloma
Janssen Research & Development, LLC1,590 enrolled265 locationsNCT05552222
Recruiting
Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All Case Investigation)
Factor Xa InhibitorLife Threatening Bleeding
AstraZeneca300 enrolled66 locationsNCT05454787
Recruiting
Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis
Rheumatoid Arthritis (RA)
Astellas Pharma Inc3,000 enrolled47 locationsNCT03971253
Recruiting
Phase 3
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Hoffmann-La Roche600 enrolled362 locationsNCT06819878
Recruiting
Phase 3
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Lung Diseases, Interstitial
GlaxoSmithKline440 enrolled131 locationsNCT06572384
Recruiting
Phase 3
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
Hypereosinophilic Syndrome
GlaxoSmithKline123 enrolled91 locationsNCT05334368
Recruiting
Phase 2Phase 3
Software as a Medical Device for the Treatment of Patients With PTSD
Post Traumatic Stress Disorder (PTSD)
Otsuka Medical Devices Co., Ltd. Japan52 enrolled35 locationsNCT06589505
Recruiting
Phase 3
ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.
Epilepsy, Generalized
Ono Pharmaceutical Co., Ltd.15 enrolled25 locationsNCT06579573